₩36,900.00 ($27.44)

-400.00 (-1.07%)

Weekly Expected Move ±5.1%

₩33135 ₩35017 ₩36900 ₩38783 ₩40665

KOE · Healthcare · Medical - Specialties · Tech Score Strong Buy · Power 70 · ₩1.68T mcap · 31M float · 1.09% daily turnover

Revenue

$474.2B +14.5% ▲

5Y CAGR: -15.9%

Gross Profit

$271.0B +13.6% ▲

5Y CAGR: -20.3%

Operating Income

$34.5B +309.7% ▲

5Y CAGR: -44.8%

Net Income

$48.4B +338.2% ▲

5Y CAGR: -37.4%

EPS (Diluted)

$927.60 +311.3% ▲

5Y CAGR: -37.4%

EBITDA

$104.6B +54.8% ▲

5Y CAGR: -31.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.37T	$853.6B	$367.4B	$414.3B	$474.2B
YoY Growth	+21.8%	-37.7%	-57.0%	+12.8%	+14.5%
Cost of Revenue	$312.1B	$387.4B	$187.3B	$175.6B	$203.3B
Gross Profit	$1.06T	$466.1B	$180.1B	$238.6B	$271.0B
Gross Margin	77.2%	54.6%	49.0%	57.6%	57.1%
R&D Expenses	$75.6B	$94.4B	$72.7B	$69.4B	$0
SG&A Expenses	$316.5B	$190.8B	$138.1B	$69.4B	$0
Operating Expenses	$392.1B	$285.2B	$210.1B	$255.1B	$236.3B
Operating Income	$666.7B	$196.5B	-$30.0B	-$16.5B	$34.5B
Operating Margin	48.6%	23.0%	-8.2%	-4.0%	7.3%
Interest Expense	$3.8B	$5.4B	$6.2B	$5.9B	$4.5B
Income Before Tax	$689.2B	$225.6B	-$1.4B	-$9.4B	$56.4B
Tax Expense	$151.6B	$43.1B	-$2.1B	$10.8B	$8.0B
Net Income	$536.6B	$182.1B	$669M	-$20.3B	$48.4B
Net Margin	39.1%	21.3%	0.2%	-4.9%	10.2%
EPS (Diluted)	$10358.00	$3586.29	$14.00	$-438.97	$927.60
EBITDA	$715.1B	$280.1B	$67.3B	$67.5B	$104.6B
Shares Outstanding	52M	51M	47M	46M	52M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$108.8B	$115.3B	$116.0B	$114.1B	$113.5B	$130.6B	$129.1B	$136.0B
Cost of Revenue	$40.8B	$59.1B	$37.3B	$44.8B	$42.4B	$54.1B	$49.5B	$52.1B
Gross Profit	$68.0B	$56.2B	$78.7B	$69.2B	$71.1B	$76.5B	$79.6B	$83.9B
Gross Margin	62.5%	48.7%	67.8%	60.7%	62.6%	58.6%	61.7%	61.7%
R&D Expenses	$15.2B	$15.8B	$13.2B	$14.8B	$15.1B	$17.6B	$11.8B	$0
SG&A Expenses	$17.5B	$18.2B	$39.7B	$66.1B	$18.2B	$23.9B	$18.9B	$23.2B
Operating Expenses	$62.7B	$62.4B	$63.9B	$66.1B	$61.5B	$69.5B	$52.2B	$62.3B
Operating Income	$5.3B	-$6.2B	$14.8B	$3.1B	$9.6B	$6.9B	$27.4B	$21.6B
Operating Margin	4.8%	-5.4%	12.8%	2.8%	8.5%	5.3%	21.2%	15.9%
Interest Expense	$1.5B	$1.4B	$1.3B	$1.2B	$1.3B	$684M	$937M	$1.0B
Income Before Tax	$1.2B	-$36.0B	$23.5B	-$798M	$18.5B	$15.2B	$39.3B	$34.5B
Tax Expense	-$526M	$8.1B	-$5.4B	-$727M	$3.9B	$10.2B	$4.6B	$8.6B
Net Income	$1.7B	-$44.0B	$28.9B	-$122M	$14.6B	$4.9B	$34.7B	$26.0B
Net Margin	1.5%	-38.1%	24.9%	-0.1%	12.8%	3.8%	26.9%	19.1%
EPS (Diluted)	$36.00	$-949.21	$626.39	$-2.64	$316.00	$97.81	$753.17	$569.00
EBITDA	$20.4B	-$17.6B	$42.1B	$87.1B	$37.2B	$24.0B	$44.0B	$37.9B
Shares Outstanding	46M	46M	46M	46M	46M	51M	52M	52M

096530.KQ KOE